USPSTF publishes B recommendation for low-dose aspirin regimen for primary prevention of colorectal cancer and cardiovascular disease

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE U.S. PREVENTATIVE SERVICES TASK FORCE published a B recommendation for low-dose aspirin use for the primary prevention of colorectal cancer and cardiovascular disease in adults aged 50 to 59 years who have a 10 percent or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login